BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 27903282)

  • 1. START NOW - a comprehensive skills training programme for female adolescents with oppositional defiant and conduct disorders: study protocol for a cluster-randomised controlled trial.
    Kersten L; Prätzlich M; Mannstadt S; Ackermann K; Kohls G; Oldenhof H; Saure D; Krieger K; Herpertz-Dahlmann B; Popma A; Freitag CM; Trestman RL; Stadler C
    Trials; 2016 Dec; 17(1):568. PubMed ID: 27903282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. START NOW: a cognitive behavioral skills training for adolescent girls with conduct or oppositional defiant disorder - a randomized clinical trial.
    Stadler C; Freitag CM; Popma A; Nauta-Jansen L; Konrad K; Unternaehrer E; Ackermann K; Bernhard A; Martinelli A; Oldenhof H; Gundlach M; Kohls G; Prätzlich M; Kieser M; Limprecht R; Raschle NM; Vriends N; Trestman RL; Kirchner M; Kersten L
    J Child Psychol Psychiatry; 2024 Mar; 65(3):316-327. PubMed ID: 37814906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emotion Regulation Difficulties in Boys with Oppositional Defiant Disorder/Conduct Disorder and the Relation with Comorbid Autism Traits and Attention Deficit Traits.
    Schoorl J; van Rijn S; de Wied M; van Goozen S; Swaab H
    PLoS One; 2016; 11(7):e0159323. PubMed ID: 27420110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long-term longitudinal course of oppositional defiant disorder and conduct disorder in ADHD boys: findings from a controlled 10-year prospective longitudinal follow-up study.
    Biederman J; Petty CR; Dolan C; Hughes S; Mick E; Monuteaux MC; Faraone SV
    Psychol Med; 2008 Jul; 38(7):1027-36. PubMed ID: 18205967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Computer-Assisted Social Skills Training in Children With Disruptive Behavior Disorders: A Randomized Controlled Trial.
    Goertz-Dorten A; Dose C; Hofmann L; Katzmann J; Groth M; Detering K; Hellmann A; Stadler L; Braun B; Hellmich M; Doepfner M
    J Am Acad Child Adolesc Psychiatry; 2022 Nov; 61(11):1329-1340. PubMed ID: 35398192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 1: psychostimulants, alpha-2 agonists, and atomoxetine.
    Pringsheim T; Hirsch L; Gardner D; Gorman DA
    Can J Psychiatry; 2015 Feb; 60(2):42-51. PubMed ID: 25886655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oppositional Defiant Disorder Is Better Conceptualized as a Disorder of Emotional Regulation.
    Cavanagh M; Quinn D; Duncan D; Graham T; Balbuena L
    J Atten Disord; 2017 Mar; 21(5):381-389. PubMed ID: 24481934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social skills training and play group intervention for children with oppositional-defiant disorders/conduct disorder: Mediating mechanisms in a head-to-head comparison.
    Katzmann J; Goertz-Dorten A; Hautmann C; Doepfner M
    Psychother Res; 2019 Aug; 29(6):784-798. PubMed ID: 29347904
    [No Abstract]   [Full Text] [Related]  

  • 9. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 2: antipsychotics and traditional mood stabilizers.
    Pringsheim T; Hirsch L; Gardner D; Gorman DA
    Can J Psychiatry; 2015 Feb; 60(2):52-61. PubMed ID: 25886656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mentalization-based treatment for adolescents with conduct disorder (MBT-CD): protocol of a feasibility and pilot study.
    Taubner S; Hauschild S; Kasper L; Kaess M; Sobanski E; Gablonski TC; Schröder-Pfeifer P; Volkert J
    Pilot Feasibility Stud; 2021 Jul; 7(1):139. PubMed ID: 34215323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany.
    Dittmann RW; Schacht A; Helsberg K; Schneider-Fresenius C; Lehmann M; Lehmkuhl G; Wehmeier PM
    J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):97-110. PubMed ID: 21488751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of individualized social competence training for children with oppositional defiant disorders/conduct disorders: a randomized controlled trial with an active control group.
    Goertz-Dorten A; Benesch C; Berk-Pawlitzek E; Faber M; Hautmann C; Hellmich M; Lindenschmidt T; Schuh L; Stadermann R; Doepfner M
    Eur Child Adolesc Psychiatry; 2019 Feb; 28(2):165-175. PubMed ID: 29594368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired neurocognitive functions affect social learning processes in oppositional defiant disorder and conduct disorder: implications for interventions.
    Matthys W; Vanderschuren LJ; Schutter DJ; Lochman JE
    Clin Child Fam Psychol Rev; 2012 Sep; 15(3):234-46. PubMed ID: 22790712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affective dysregulation in childhood - optimizing prevention and treatment: protocol of three randomized controlled trials in the ADOPT study.
    Döpfner M; Katzmann J; Hanisch C; Fegert JM; Kölch M; Ritschel A; Treier AK; Hellmich M; Roessner V; Ravens-Sieberer U; Banaschewski T; Görtz-Dorten A;
    BMC Psychiatry; 2019 Sep; 19(1):264. PubMed ID: 31477086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emotional valence detection in adolescents with oppositional defiant disorder/conduct disorder or autism spectrum disorder.
    Herpers PCM; Bakker-Huvenaars MJ; Greven CU; Wiegers EC; Nijhof KS; Baanders AN; Buitelaar JK; Rommelse NNJ
    Eur Child Adolesc Psychiatry; 2019 Jul; 28(7):1011-1022. PubMed ID: 30680520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbidity as a predictor and moderator of treatment outcome in youth with anxiety, affective, attention deficit/hyperactivity disorder, and oppositional/conduct disorders.
    Ollendick TH; Jarrett MA; Grills-Taquechel AE; Hovey LD; Wolff JC
    Clin Psychol Rev; 2008 Dec; 28(8):1447-71. PubMed ID: 18973971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of a school-based prevention and early intervention program to reduce oppositional defiant disorder/conduct disorder.
    Winther J; Carlsson A; Vance A
    Early Interv Psychiatry; 2014 May; 8(2):181-9. PubMed ID: 23734628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TIGA-CUB - manualised psychoanalytic child psychotherapy versus treatment as usual for children aged 5-11 years with treatment-resistant conduct disorders and their primary carers: study protocol for a randomised controlled feasibility trial.
    Edginton E; Walwyn R; Burton K; Cicero R; Graham L; Reed S; Tubeuf S; Twiddy M; Wright-Hughes A; Ellis L; Evans D; Hughes T; Midgley N; Wallis P; Cottrell D
    Trials; 2017 Sep; 18(1):431. PubMed ID: 28915904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics associated with conduct disorder, oppositional defiant disorder and comorbidity].
    Lapalme M; Déry M
    Sante Ment Que; 2008; 33(2):185-206. PubMed ID: 19370263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Family-based psychosocial interventions for children with attention deficit hyperactivity disorder (ADHD), oppositional defiant disorder, and conduct disorder].
    Vuori M; Tuulio-Henriksson A; Nissinen H; Autti-Rämö I
    Duodecim; 2015; 131(17):1561-8. PubMed ID: 26548103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.